Vicor Technologies, Inc., Boca Raton, FL, USA.
Clin Neurophysiol. 2011 Jul;122(7):1457-62. doi: 10.1016/j.clinph.2010.12.046. Epub 2011 Jan 21.
The aim of this study was to test whether a new heart rate variability (HRV) complexity measure, the Point Correlation Dimension (PD2i), provides diagnostic information regarding early subclinical autonomic dysfunction in diabetes mellitus (DM). We tested the ability of PD2i to detect diabetic autonomic neuropathy (DAN) in asymptomatic young DM patients without overt neuropathy and compared them to age- and gender-matched controls.
HRV in DM type 1 patients (n=17, 10 female, 7 male) aged 12.9-31.5 years (duration of DM 12.4±1.2 years) was compared to that in a control group of 17 healthy matched probands. The R-R intervals were measured over 1h using a telemetric ECG system.
PD2i was able to detect ANS dysfunction with p=0.0006, similar to the best discriminating MSE scale, with p=0.0002.
The performance of PD2i to detect DAN in asymptomatic DM patients is similar to the best discriminative power of previously published complexity measures.
The PD2i algorithm may prove to be an easy to perform and clinically useful tool for the early detection of autonomic neuropathy in DM type 1 patients, especially given its minimal data requirements.
本研究旨在测试新的心率变异性(HRV)复杂度指标——点关联维数(PD2i)是否提供了有关糖尿病(DM)早期亚临床自主神经功能障碍的诊断信息。我们测试了 PD2i 检测无症状年轻 1 型糖尿病患者(无明显神经病变)的糖尿病自主神经病变(DAN)的能力,并将其与年龄和性别匹配的对照组进行了比较。
将 17 名年龄在 12.9-31.5 岁(DM 病程 12.4±1.2 年)的 1 型糖尿病患者的 HRV 与 17 名健康匹配的对照者的 HRV 进行比较。使用遥测心电图系统测量了 1 小时的 R-R 间隔。
PD2i 能够以 p=0.0006 的水平检测到 ANS 功能障碍,与最佳区分 MSE 量表的 p=0.0002 水平相似。
PD2i 检测无症状 DM 患者 DAN 的性能与之前发表的复杂度指标的最佳判别能力相似。
PD2i 算法可能成为检测 1 型糖尿病患者自主神经病变的一种易于操作且具有临床意义的工具,特别是考虑到其对数据的最小要求。